Gut markers for metastatic melanoma receiving immunotherapy
Further detection of gut markers (Amc and Bvu) could better predict patients' responsiveness to immunotherapy.
Authors
- Juhua Gou
- Yu Cheng Zhu (ORCID: https://orcid.org/0000-0003-1971-7784)
- Huajing Ou
- Hailin Zheng (ORCID: https://orcid.org/0000-0003-0247-1853)
- Guoping Ou
- Xiaohua Liu (ORCID: https://orcid.org/0000-0001-8661-3032)
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
- Chongqing Public Health Medical Center (CN)
- First People's Hospital of Chongqing (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1186/s12885-025-14467-4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Sun Yat-sen University
- Sun Yat-sen University Cancer Center